ELIC — Elicera Therapeutics AB Share News
0.000.00%
Last trade - 00:00- SEK189.29m
- SEK171.42m
- SEK10.86m
Brief: Elicera Enters Agreement With Prominent US Cancer Center
Brief: Elicera Therapeutics Q4 EPS SEK -0.24
Brief: Elicera Therapeutics Proposes Dividend Of SEK 0.00 Per Share
Brief: Elicera Therapeutics Gets Approval To Initiate Clinical Phase I/II-Study CARMA
Brief: Elicera Proposes Rights Issue Of Units Of SEK 64 Mln
Founder Receives Grant Of SEK 4.8 Mln
Brief: Elicera Therapeutics Q3 Operating Loss Narrows To SEK 5.1 Million
Brief: Elicera Therapeutics Q3 Adjusted EPS SEK -0.16
Brief: Elicera Therapeutics Receives Allowance For Chinese Patent
Brief: Elicera Therapeutics Q2 Operating Loss Widens To SEK 4.5 Mln
Brief: Elicera Therapeutics Q2 Adjusted EPS at SEK -0.22
Brief: Elicera Receives Notice Of Allowance For European Patent
Brief: Elicera Therapeutics Q1 Adj. EPS at SEK -0.11
Brief: Elicera Therapeutics Q4 Oper Loss Widens To SEK 4 Mln
Brief: Elicera Therapeutics Submits Clinical Trial Application
Brief: Elicera Therapeutics Reports Additional Signals Of Clinical Activity In ELC-100 Study
Brief: Elicera Therapeutics Q3 Operating Loss Widens To SEK 7 Million
Founders Receive Additional Grants
Brief: Elicera Therapeutics Enters Collaboration With Spanish Research Institution